A study of correlation between lipid peroxide and HbA1C in the diabetic patients

 

 

REFERENCES

1. William T. Marshall, Stephen K Bangert Clinical Biochemistry, Metabolic and
2. Clinical aspects, second edition. Churchill Livingstone, 2008: 946-947. Donald Voet Judith G. Voet, Charlotte W Pratt, Fundamental of Biochemistry, 2 nd Edition, John Wiley andamp; sons pte ltd, 2006; 21:779.
3. Lee Gold Man, Dennis Ausiello Cecil text book of medicine 22 nd edition vol II; 242: 1429.
4. Jain AP and Gupta DP, Study of blood lipids in diabetes without any manifest vascular complications. J.Dia Asso Ind Vol XX, 29-34.
5. Y Sachdev, Clinical Endocrinology and DM,Ist edition , Volume I ; 2008: 41, 394
6. Stewart ML, LakerMF, Dyer RG, Game FL, Mitcheson J, Winocour PH Alberti Kamm, Lipoprotein Compositional abnormalities and insulin resistance in type 2 diabetic patients with mild hyperlipidaemia Arteriosclero; B: 1046-52.
7. DM Vasudevan, Sreekumaris. Text book of Biochemistry for Medical students 5^th edition, 2007; 13: 161.
8. John Betteridge, Lipids and Vascular disease current issues marten Dunitz ltd, UK, 2000, 4: 39-41.
9. Aruoma OI, Halliwell B, Butter J, Honey BM, Apparent inactivation of1, antioproteinase by sulphur containing radicals derived from penicillamine. Biochem pharmacol 1989; 38: 4353-4357.
10. N. P. Suryawanshi, A. K. Bhutey, A. N. Nagdeote, A.A.Jadhav and G.S.Manoorkar. Study of lipid peroxide and lipid profile in Diabetes Mellitus. Indian journal of clinical Biochemistry, 2006; 21:126-130.
11. Sayday SH, Ebarhardt, MS, Loria cm, et al, Age and burden of death attributable to diabetes in the united states. AM. Epideiol: 2002; 156:714-719.
12. Anne Peters Harmel, MD, Ruchi Mathur MD, Davinson’s diabetes mellitus diagnosis and treatment, 5 th Edition 2004; 8: 246.
13. Cathcard MK,Folcik VA, Lipoxygenases and atherosclerosis.. Protection versus pathogenesis, Free Radic Biol Med 2000; 28:1726-34.
14. Kuhn H, Chan L, The role of 15-Lipoxygenase in atherogenesis; pro and antiaatherogenic actions, Curropin Lipidol 1997; 8:111-17.
15. Yia-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J.clinInvest 1989; 84:1086-95.
16. Parthasarathy S,RankinSM, Role of oxidized LDL in atherogenesis Prog Lipid Res 1992:31:127-43.
17. Berliner TA, Navab M, Fogelman AM et al. Basic Mechanisms oxidation, Inflammation and genetics, Correlation 1995; 91:2488-96.
18. BerlinerTA, HeineckeJW, The role of oxidized LP in atherogenesis. Free Rad Biol Med 1996; 20:707-27.
19. Steinberg D. Oxidative Modification of LDL and atherogenesis, Circulation 1997; 95:1062-71.
20. Jain Meenu, Jadeja Jayendrasinh M, Mehta Neeta. Correlation Between HbA1c Values And Lipid Profile In Type 2 Diabetes Mellitus.International Journal of Basic and Applied Physiology 2013; 2 (1): 47-50.